10 Best Pet Stocks To Buy Now
The pet industry saw a huge growth in 2020 amid the coronavirus crisis. As people were forced to stay at home, they preferred to spend time with pets.
Posts Tagged ‘NYSE:MRK’
5 Best Pet Stocks To Buy Now
Headquartered in Indiana, United States, Elanco Animal Health, Inc. operates an innovative and product and solution company that aims to enhance animal health.
20 Most Deadliest and Dangerous Snakes In the World
Today we are going to take you for a thrilling virtual tour to the world of the 20 most deadliest and dangerous snakes in the world.
Merck (MRK) Stock Trading Lower Since Q4 Earnings Report
Merck & Co. Inc. (NYSE:MRK) history dates back to 1891 when 23 years old George Merck established the company to supply fine chemicals in New York City and adjacent areas.
Top 10 Large-Cap Healthcare Stocks to Buy Now
The healthcare industry has been one of the strongest drivers of GDP growth in recent decades, which has translated into massive returns for healthcare stocks.
Billionaire David Siegel’s Top 10 Stock Picks
In this article we discuss quant billionaire David Siegel's top 10 stock picks.
Is Merck (MRK) A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
15 Best Blue Chip Stocks to Buy Now
In this article, we presented the list of the 15 best blue chip stocks to buy now.
Top 5 Stocks Warren Buffett Just Bought
In this article we’ll check out the Top 5 Stocks Warren Buffett Just Bought.
10 Biggest Pharmaceutical Companies in the World in 2020
In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 (click to skip ahead and see the top 3 pharma...
Hedge Funds Cashing Out Of Merck (MRK)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: Nicolai Tangen, Ken Griffin, Spruce Point Management, Lighthaven Capital Management, Pfizer Inc. (PFE), Northern Dynasty Minerals Ltd (NAK), and More
Eric Chung, chief investment officer of Lighthaven Capital Management, joined the Contrarian Investor Podcast to discuss his view that math, financial models, and algorithms are...
Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Why Growth Investors will Love These 2 Healthcare Stocks
Saturna Capital Corporation is the investment management company of Sextant Mutual Funds.
2 “Strong Buy” Healthcare Stocks That Offer Massive Potential Gains
Antipodes Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Here is How Hedge Funds Traded Merck & Co. (MRK) During The Crash
In this article you are going to find out whether hedge funds think Merck & Co., Inc. (NYSE:MRK) is a good investment right now.
Hedge Fund Manager: Merck Is Slightly Attractive But Close To Fair Value
Michael Castor predicted the coronavirus pandemic when most investors were dismissing the threat.
Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
We hate to say this but, we told you so.
Merck & Co., Inc. (MRK): Are Hedge Funds Right About This Stock?
Does Merck & Co., Inc. (NYSE:MRK) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Hedge Fund Consensus Stocks vs. Merck & Co., Inc. (MRK) In 2019
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards...
Hedge Funds Are Optimistic About Merck & Co., Inc. (MRK)
We can judge whether Merck & Co., Inc. (NYSE:MRK) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Here is Hedge Funds’ 30th Most Popular Stock Pick
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Is Merck & Co., Inc. (MRK) A Good Stock To Buy ?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
3 Stocks Billionaire Dan Loeb Bought in Q3 (and 2 He Dumped)
Billionaire Dan Loeb, the founder of $18 billion hedge fund Third Point, is mired in a fourth-straight year of trailing the market, though the activist fund did return a solid...
Here is What Hedge Funds Are Thinking About Merck & Co., Inc. (MRK)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter.
Don’t Be Fooled by the Recent Selling; Hedge Funds Still Love Merck & Co., Inc. (MRK)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Hedge Fund and Insider Trading News: Tom Steyer, Edward Lampert, Merck & Co., Inc. (MRK), Fiserv Inc (FISV), Alteryx Inc (AYX), and More
Liberal billionaire Tom Steyer claims to be building a juggernaut political operation in support of impeaching President Trump, rallying the base and creating a "digital army" ...
Hedge Fund and Insider Trading News: Andreas Halvorsen, Bill Ackman, Paulson & Co., Merck & Co., Inc. (MRK), Arvinas Inc (ARVN), Y-mAbs Therapeutics (YMAB), and More
Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds a 75.6% stake in urologic biopharmaceutical company Urovant Sciences Ltd.
Market Movers Today: Merck & Co., Inc. (MRK), Under Armour Inc (UA), General Electric Company (GE), and More
On Tuesday before the market opened, shares of Merck & Co ($MRK) were gapping up on news of positive results from their lung cancer trial.
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
15 Biggest Healthcare Companies in USA
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Should You Follow Hedge Funds Into These Healthcare Stocks?
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually in an attempt to stay healthy...
Merck & Co. Inc. (MRK) Opens in Green Amid FDA Rejection Related to Diabetes Drugs
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S.
10 Biggest Recent Accounting Scandals in America
The 10 biggest recent accounting scandals in America have shaken the nation and affected investor confidence.
10 Least Obese Countries in the World
The 10 least obese countries in the world are mostly from Asia and Africa.
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc.
Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis drug it owns.
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years.
The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA.
The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co., Inc. (MRK)
The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK).
Pharmaceutical Executives From Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ) Met Trump
United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher cost manufacturing at the...
Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes.
